Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 142359, 13 pages
http://dx.doi.org/10.1155/2015/142359
Review Article

The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis

Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirão Preto Medical School, University of São Paulo, 14049-900 Ribeirão Preto, SP, Brazil

Received 18 December 2014; Accepted 13 February 2015

Academic Editor: Francesco Moccia

Copyright © 2015 Devandir Antonio de Souza Junior et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Folkman and Y. Shing, “Angiogenesis,” The Journal of Biological Chemistry, vol. 267, no. 16, pp. 10931–10934, 1992. View at Google Scholar · View at Scopus
  2. T. O. Daniel and D. Abrahamson, “Endothelial signal integration in vascular assembly,” Annual Review of Physiology, vol. 62, pp. 649–671, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Ribatti, “Genetic and epigenetic mechanisms in the early development of the vascular system,” Journal of Anatomy, vol. 208, no. 2, pp. 139–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Ribatti and E. Crivellato, “Mast cells, angiogenesis, and tumour growth,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1822, no. 1, pp. 2–8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Hanahan and J. Folkman, “Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis,” Cell, vol. 86, no. 3, pp. 353–364, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. M. L. Iruela-Arispe and H. F. Dvorak, “Angiogenesis: a dynamic balance of stimulators and inhibitors,” Thrombosis and Haemostasis, vol. 78, no. 1, pp. 672–677, 1997. View at Google Scholar · View at Scopus
  7. M. Sawatsubashi, T. Yamada, N. Fukushima, H. Mizokami, O. Tokunaga, and T. Shin, “Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma,” Virchows Archiv, vol. 436, no. 3, pp. 243–248, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Talreja, M. H. Kabir, M. B. Filla, D. J. Stechschulte, and K. N. Dileepan, “Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components,” Immunology, vol. 113, no. 2, pp. 224–233, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Hobson and J. Denekamp, “Endothelial proliferation in tumours and normal tissues: continuous labelling studies,” British Journal of Cancer, vol. 49, no. 4, pp. 405–413, 1984. View at Publisher · View at Google Scholar · View at Scopus
  10. P. A. D'Amore and R. W. Thompson, “Mechanisms of angiogenesis,” Annual Review of Physiology, vol. 49, pp. 453–464, 1987. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Le Querrec, D. Duval, and G. Tobelem, “Tumour angiogenesis,” Bailliere's Clinical Haematology, vol. 6, no. 3, pp. 711–730, 1993. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Potente, H. Gerhardt, and P. Carmeliet, “Basic and therapeutic aspects of angiogenesis,” Cell, vol. 146, no. 6, pp. 873–887, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Goldmann, “The growth of malignant disease in man and the lower animals, with special reference to the vascular system,” Proceedings of the Royal Society of Medicine, Surgery Section, vol. 1, pp. 1–13, 1908. View at Google Scholar
  14. J. Folkman, “Tumor angiogenesis: therapeutic implications,” The New England Journal of Medicine, vol. 285, no. 21, pp. 1182–1186, 1971. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Ranieri, C. D. Gadaleta, R. Patruno et al., “A model of study for human cancer: spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies,” Critical Reviews in Oncology/Hematology, vol. 88, no. 1, pp. 187–197, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Ranieri, M. Pantaleo, M. Piccinno et al., “Tyrosine kinase inhibitors (TKIs) in human and pet tumours with special reference to breast cancer: a comparative review,” Critical Reviews in Oncology/Hematology, vol. 88, no. 2, pp. 293–308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Al-Husein, M. Abdalla, M. Trepte, D. L. DeRemer, and P. R. Somanath, “Antiangiogenic therapy for cancer: an update,” Pharmacotherapy, vol. 32, no. 12, pp. 1095–1111, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A. W. Griffioen and G. Molema, “Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation,” Pharmacological Reviews, vol. 52, no. 2, pp. 237–268, 2000. View at Google Scholar · View at Scopus
  19. P. Carmeliet and R. K. Jain, “Molecular mechanisms and clinical applications of angiogenesis,” Nature, vol. 473, no. 7347, pp. 298–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Moccia, S. Dragoni, V. Poletto et al., “Orai1 and transient receptor potential channels as novel molecular targets to impair tumor neovascularization in renal cell carcinoma and other malignancies,” Anti-Cancer Agents in Medicinal Chemistry, vol. 14, no. 2, pp. 296–312, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Marichal, M. Tsai, and S. J. Galli, “Mast cells: potential positive and negative roles in tumor biology,” Cancer Immunology Research, vol. 1, no. 5, pp. 269–279, 2013. View at Publisher · View at Google Scholar
  22. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Ribatti and E. Crivellato, “Immune cells and angiogenesis,” Journal of Cellular and Molecular Medicine, vol. 13, no. 9, pp. 2822–2833, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Z. M. da Silva, M. C. Jamur, and C. Oliver, “Mast cell function: a new vision of an old cell,” Journal of Histochemistry & Cytochemistry, vol. 62, no. 10, pp. 698–738, 2014. View at Publisher · View at Google Scholar
  25. S. J. Galli, J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. M. Williams, and M. Tsai, “Mast cells as ‘tunable’ effector and immunoregulatory cells: recent advances,” Annual Review of Immunology, vol. 23, pp. 749–786, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. F. Gurish and K. F. Austen, “Developmental origin and functional specialization of mast cell subsets,” Immunity, vol. 37, no. 1, pp. 25–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. F. Gurish and J. A. Boyce, “Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell,” The Journal of Allergy and Clinical Immunology, vol. 117, no. 6, pp. 1285–1291, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. K. D. Stone, C. Prussin, and D. D. Metcalfe, “IgE, mast cells, basophils, and eosinophils,” Journal of Allergy and Clinical Immunology, vol. 125, no. 2, supplement 2, pp. S73–S80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. C. Jamur and C. Oliver, “Origin, maturation and recruitment of mast cell precursors,” Frontiers in Bioscience, vol. 3, no. 4, pp. 1390–1406, 2011. View at Google Scholar · View at Scopus
  30. D. D. Metcalfe, R. D. Peavy, and A. M. Gilfillan, “Mechanisms of mast cell signaling in anaphylaxis,” Journal of Allergy and Clinical Immunology, vol. 124, no. 4, pp. 639-646, 647–638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. H. R. Katz, M. B. Raizman, C. S. Gartner, H. C. Scott, A. C. Benson, and K. F. Austen, “Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells,” Journal of Immunology, vol. 148, no. 3, pp. 868–871, 1992. View at Google Scholar · View at Scopus
  32. J. W. Coleman, M. R. Holliday, I. Kimber, K. M. Zsebo, and S. J. Galli, “Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4,” The Journal of Immunology, vol. 150, no. 2, pp. 556–562, 1993. View at Google Scholar · View at Scopus
  33. S. J. Galli, A. Iemura, D. S. Garlick, C. Gamba-Vitalo, K. M. Zsebo, and R. G. Andrews, “Reversible expansion of primate mast cell populations in vivo by stem cell factor,” The Journal of Clinical Investigation, vol. 91, no. 1, pp. 148–152, 1993. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Supajatura, H. Ushio, A. Nakao et al., “Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity,” Journal of Clinical Investigation, vol. 109, no. 10, pp. 1351–1359, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. S. J. Galli, S. Nakae, and M. Tsai, “Mast cells in the development of adaptive immune responses,” Nature Immunology, vol. 6, no. 2, pp. 135–142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. R. T. Venkatesha, E. B. Thangam, A. K. Zaidi, and H. Ali, “Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase,” Molecular Immunology, vol. 42, no. 5, pp. 581–587, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. S. J. Galli and M. Tsai, “Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis,” Journal of Dermatological Science, vol. 49, no. 1, pp. 7–19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. H. R. Katz, J. P. Arm, A. C. Benson, and K. F. Austen, “Maturation-related changes in the expression of FcγRII and FcγRIII on mouse mast cells derived in vitro and in vivo,” The Journal of Immunology, vol. 145, no. 10, pp. 3412–3417, 1990. View at Google Scholar · View at Scopus
  39. G. Pejler, M. Åbrink, M. Ringvall, and S. Wernersson, “Mast cell proteases,” Advances in Immunology, vol. 95, pp. 167–255, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. L. B. Schwartz and T. R. Bradford, “Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer,” Journal of Biological Chemistry, vol. 261, no. 16, pp. 7372–7379, 1986. View at Google Scholar · View at Scopus
  41. L. B. Schwartz, A. M. A. Irani, K. Roller, M. C. Castells, and N. M. Schechter, “Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells,” Journal of Immunology, vol. 138, no. 8, pp. 2611–2615, 1987. View at Google Scholar · View at Scopus
  42. C. Huang, G. Morales, A. Vagi et al., “Formation of enzymatically active, homotypic, and heterotypic tetramers of mouse mast cell tryptases. Dependence on a conserved Trp-rich domain on the surface,” Journal of Biological Chemistry, vol. 275, no. 1, pp. 351–358, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Pejler, S. D. Knight, F. Henningsson, and S. Wernersson, “Novel insights into the biological function of mast cell carboxypeptidase A,” Trends in Immunology, vol. 30, no. 8, pp. 401–408, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. F. R. Melo, I. Waern, E. Rönnberg et al., “A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway,” The Journal of Biological Chemistry, vol. 286, no. 7, pp. 5423–5433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Åbrink, M. Grujic, and G. Pejler, “Serglycin is essential for maturation of mast cell secretory granule,” The Journal of Biological Chemistry, vol. 279, no. 39, pp. 40897–40905, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Braga, M. Grujic, A. Lukinius, L. Hellman, M. Åbrink, and G. Pejler, “Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells,” Biochemical Journal, vol. 403, no. 1, pp. 49–57, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. S. J. Galli, N. Borregaard, and T. A. Wynn, “Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils,” Nature Immunology, vol. 12, no. 11, pp. 1035–1044, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. J. P. Abonia, C. Blanchard, B. B. Butz et al., “Involvement of mast cells in eosinophilic esophagitis,” Journal of Allergy and Clinical Immunology, vol. 126, no. 1, pp. 140–149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. R. H. Dougherty, S. S. Sidhu, K. Raman et al., “Accumulation of intraepithelial mast cells with a unique protease phenotype in TH2-high asthma,” The Journal of Allergy and Clinical Immunology, vol. 125, no. 5, pp. 1046.e8–1053.e8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. R. L. Stevens, D. S. Friend, H. P. Mcneil, V. Schiller, N. Ghildyal, and K. F. Austen, “Strain-specific and tissue-specific expression of mouse mast cell secretory granule proteases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 1, pp. 128–132, 1994. View at Publisher · View at Google Scholar · View at Scopus
  51. M. F. Gurish, W. S. Pear, R. L. Stevens et al., “Tissue-regulated differentiation and maturation of a v-abl-immortalized mast cell-committed progenitor,” Immunity, vol. 3, no. 2, pp. 175–186, 1995. View at Publisher · View at Google Scholar · View at Scopus
  52. D. S. Friend, N. Ghildyal, K. F. Austen, M. F. Gurish, R. Matsumoto, and R. L. Stevens, “Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype,” Journal of Cell Biology, vol. 135, no. 1, pp. 279–290, 1996. View at Publisher · View at Google Scholar · View at Scopus
  53. W. Xing, K. F. Austen, M. F. Gurish, and T. G. Jones, “Protease phenotype of constitutive connective tissue and of induced mucosal mast cells in mice is regulated by the tissue,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 34, pp. 14210–14215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. H. P. McNeil, K. Shin, I. K. Campbell et al., “The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis,” Arthritis and Rheumatism, vol. 58, no. 8, pp. 2338–2346, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Shin, G. F. M. Watts, H. C. Oettgen et al., “Mouse mast cell tryptase mMCP-6 Is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection,” Journal of Immunology, vol. 180, no. 7, pp. 4885–4891, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. Q. Sun, W. Li, R. She et al., “Evidence for a role of mast cells in the mucosal injury induced by Newcastle disease virus,” Poultry Science, vol. 88, no. 3, pp. 554–561, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Scandiuzzi, W. Beghdadi, E. Daugas et al., “Mouse mast cell protease-4 deteriorates renal function by contributing to inflammation and fibrosis in immune complex-mediated glomerulonephritis,” Journal of Immunology, vol. 185, no. 1, pp. 624–633, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Lambiase, A. Micera, and S. Bonini, “Multiple action agents and the eye: do they really stabilize mast cells?” Current Opinion in Allergy and Clinical Immunology, vol. 9, no. 5, pp. 454–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. D. A. de Souza Jr., V. D. Toso, M. R. D. C. Campos, V. S. Lara, C. Oliver, and M. C. Jamur, “Expression of mast cell proteases correlates with mast cell maturation and angiogenesis during tumor progression,” PLoS ONE, vol. 7, no. 7, Article ID e40790, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Ehrlich, Beiträge zur Theorie und Praxis der Histologischen Färbung, 1878.
  61. S. Ch'ng, R. A. Wallis, L. Yuan, P. F. Davis, and S. T. Tan, “Mast cells and cutaneous malignancies,” Modern Pathology, vol. 19, no. 1, pp. 149–159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Gulubova and T. Vlaykova, “Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer,” Journal of Gastroenterology and Hepatology, vol. 24, no. 7, pp. 1265–1275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. G. Ranieri, M. Ammendola, R. Patruno et al., “Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients,” International Journal of Oncology, vol. 35, no. 1, pp. 115–120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Mangia, A. Malfettone, R. Rossi et al., “Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation,” Histopathology, vol. 58, no. 7, pp. 1096–1106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. I. Takanami, K. Takeuchi, and M. Naruke, “Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma,” Cancer, vol. 88, no. 12, pp. 2686–2692, 2000. View at Google Scholar
  66. S. Dabiri, D. Huntsman, N. Makretsov et al., “The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis,” Modern Pathology, vol. 17, no. 6, pp. 690–695, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Conti, M. L. Castellani, D. Kempuraj et al., “Role of mast cells in tumor growth,” Annals of Clinical and Laboratory Science, vol. 37, no. 4, pp. 315–322, 2007. View at Google Scholar · View at Scopus
  68. B. L. Gruber, M. J. Marchese, and R. Kew, “Angiogenic factors stimulate mast-cell migration,” Blood, vol. 86, no. 7, pp. 2488–2493, 1995. View at Google Scholar · View at Scopus
  69. B. Huang, Z. Lei, G.-M. Zhang et al., “SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment,” Blood, vol. 112, no. 4, pp. 1269–1279, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. L. Benítez-Bribiesca, A. Wong, D. Utrera, and E. Castellanos, “The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix,” Journal of Histochemistry and Cytochemistry, vol. 49, no. 8, pp. 1061–1062, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. M. P. Wymann, K. Björklöf, R. Calvez et al., “Phosphoinositide 3-kinase γ: a key modulator in inflammation and allergy,” Biochemical Society Transactions, vol. 31, part 1, pp. 275–280, 2003. View at Google Scholar · View at Scopus
  72. M. A. Grimbaldeston, A. L. Pearce, B. O. Robertson et al., “Association between melanoma and dermal mast cell prevalence in sun-unexposed skin,” British Journal of Dermatology, vol. 150, no. 5, pp. 895–903, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. D. Ribatti, N. Finato, E. Crivellato et al., “Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer,” The American Journal of Obstetrics and Gynecology, vol. 193, no. 6, pp. 1961–1965, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Yoshii, A. Jikuhara, S. Mori et al., “Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners,” Journal of Pharmacological Sciences, vol. 98, no. 4, pp. 450–458, 2005. View at Google Scholar · View at Scopus
  75. N. C. Diaconu, R. Kaminska, A. Naukkarinen, R. J. Harvima, and I. T. Harvima, “The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma,” Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 7, pp. 908–915, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. N. Nonomura, H. Takayama, K. Nishimura et al., “Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer,” British Journal of Cancer, vol. 97, no. 7, pp. 952–956, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Fleischmann, T. Schlomm, J. Köllermann et al., “Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis,” Prostate, vol. 69, no. 9, pp. 976–981, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. M. J. Carlini, M. C. L. Dalurzo, J. M. Lastiri et al., “Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance,” Human Pathology, vol. 41, no. 5, pp. 697–705, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Johansson, S. Rudolfsson, P. Hammarsten et al., “Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy,” The American Journal of Pathology, vol. 177, no. 2, pp. 1031–1041, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. D. Ribatti, D. Guidolin, A. Marzullo et al., “Mast cells and angiogenesis in gastric carcinoma,” International Journal of Experimental Pathology, vol. 91, no. 4, pp. 350–356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. G. Dyduch, K. Kaczmarczyk, and K. Okoń, “Mast cells and cancer: enemies or allies?” Polish Journal of Pathology, vol. 63, no. 1, pp. 1–7, 2012. View at Google Scholar · View at Scopus
  82. D. Ribatti, A. Vacca, B. Nico, E. Crivellato, L. Roncali, and F. Dammacco, “The role of mast cells in tumour angiogenesis,” British Journal of Haematology, vol. 115, no. 3, pp. 514–521, 2001. View at Publisher · View at Google Scholar · View at Scopus
  83. E. Crivellato, C. A. Beltrami, F. Mallardi, and D. Ribatti, “The mast cell: an active participant or an innocent bystander?” Histology and Histopathology, vol. 19, no. 1, pp. 259–270, 2004. View at Google Scholar · View at Scopus
  84. X. Tan, S. Essengue, J. Talreja, J. Reese, D. J. Stechschulte, and K. N. Dileepan, “Histamine directly and synergistically with lipopolysaccharide stimulates cyclooxygenase-2 expression and prostaglandin I2 and E2 production in human coronary artery endothelial cells,” Journal of Immunology, vol. 179, no. 11, pp. 7899–7906, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Muramatsu, J. Katada, M. Hattori, I. Hayashi, and M. Majima, “Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas,” European Journal of Pharmacology, vol. 402, no. 1-2, pp. 181–191, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Muramatsu, J. Katada, I. Hayashi, and M. Majima, “Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model,” The Journal of Biological Chemistry, vol. 275, no. 8, pp. 5545–5552, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. T. Tth, R. Tth-Jakatics, S. Jimi, S. Takebayashi, and N. Kawamoto, “Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor,” Human Pathology, vol. 31, no. 8, pp. 955–960, 2000. View at Publisher · View at Google Scholar · View at Scopus
  88. K. Norrby, “Mast cells and angiogenesis,” Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 110, no. 5, pp. 355–371, 2002. View at Publisher · View at Google Scholar · View at Scopus
  89. I. Feoktistov, S. Ryzhov, A. E. Goldstein, and I. Biaggioni, “Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors,” Circulation Research, vol. 92, no. 5, pp. 485–492, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Juczewska and L. Chyczewski, “Angiogenesis in cancer,” Roczniki Akademii Medycznej w Białymstoku, vol. 42, supplement 1, pp. 86–100, 1997. View at Google Scholar · View at Scopus
  91. L. B. Schwartz, R. A. Lewis, and K. F. Austen, “Tryptase from human pulmonary mast cells. Purification and characterization.,” The Journal of Biological Chemistry, vol. 256, no. 22, pp. 11939–11943, 1981. View at Google Scholar · View at Scopus
  92. L. B. Schwartz, “Tryptase, a mediator of human mast cells,” Journal of Allergy and Clinical Immunology, vol. 86, no. 4, pp. 594–598, 1990. View at Publisher · View at Google Scholar · View at Scopus
  93. V. Payne and P. C. A. Kam, “Mast cell tryptase: a review of its physiology and clinical significance,” Anaesthesia, vol. 59, no. 7, pp. 695–703, 2004. View at Publisher · View at Google Scholar · View at Scopus
  94. G. Pejler, E. Rönnberg, I. Waern, and S. Wernersson, “Mast cell proteases: multifaceted regulators of inflammatory disease,” Blood, vol. 115, no. 24, pp. 4981–4990, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. H.-Z. Xia, C. L. Kepley, K. Sakai, J. Chelliah, A.-M. A. Irani, and L. B. Schwartz, “Quantitation of tryptase, chymase, FcεRlα, and FcεRlγ mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction,” Journal of Immunology, vol. 154, no. 10, pp. 5472–5480, 1995. View at Google Scholar · View at Scopus
  96. S. Wernersson and G. Pejler, “Mast cell secretory granules: armed for battle,” Nature Reviews Immunology, vol. 14, no. 7, pp. 478–494, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. J. P. Kankkunen, I. T. Harvima, and A. Naukkarinen, “Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions,” International Journal of Cancer, vol. 72, no. 3, pp. 385–388, 1997. View at Google Scholar
  98. A. Imada, N. Shijubo, H. Kojima, and S. Abe, “Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma,” European Respiratory Journal, vol. 15, no. 6, pp. 1087–1093, 2000. View at Publisher · View at Google Scholar · View at Scopus
  99. B. Nico, A. Marzullo, P. Corsi, A. Vacca, L. Roncali, and D. Ribatti, “A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy,” Neuroscience, vol. 123, no. 3, pp. 585–588, 2004. View at Publisher · View at Google Scholar · View at Scopus
  100. D. Ribatti, S. Molica, A. Vacca et al., “Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia,” Leukemia, vol. 17, no. 7, pp. 1428–1430, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. D. Ribatti, M. G. Ennas, A. Vacca et al., “Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma,” European Journal of Clinical Investigation, vol. 33, no. 5, pp. 420–425, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. V. Goffredo, C. D. Gadaleta, A. Laterza, A. Vacca, and G. Ranieri, “Tryptase serum levels in patients suffering from hepatocellular carcinoma undergoing intra-arterial chemoembolization: possible predictive role of response to treatment,” Molecular and Clinical Oncology, vol. 1, no. 2, pp. 385–389, 2013. View at Publisher · View at Google Scholar
  103. M. Ammendola, R. Sacco, G. Donato et al., “Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically,” Oncology, vol. 85, no. 2, pp. 111–116, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. I. Marech, M. Ammendola, R. Sacco et al., “Serum tryptase, mast cells positive to tryptase and microvascular density evaluation in early breast cancer patients: possible translational significance,” BMC Cancer, vol. 14, article 534, 2014. View at Publisher · View at Google Scholar
  105. I. Marech, M. Ammendola, C. Gadaleta et al., “Possible biological and translational significance of mast cells density in colorectal cancer,” The World Journal of Gastroenterology, vol. 20, no. 27, pp. 8910–8920, 2014. View at Google Scholar
  106. T. C. Theoharides, K.-D. Alysandratos, A. Angelidou et al., “Mast cells and inflammation,” Biochimica et Biophysica Acta, vol. 1822, no. 1, pp. 21–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. A. Malfettone, N. Silvestris, C. Saponaro et al., “High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression,” Journal of Cellular and Molecular Medicine, vol. 17, no. 8, pp. 1025–1037, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. M. Ammendola, Ch. Leporini, I. Marech et al., “Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy,” BioMed Research International, vol. 2014, Article ID 154702, 16 pages, 2014. View at Publisher · View at Google Scholar
  109. C. M. Kielty, M. Lees, C. A. Shuttleworth, and D. Woolley, “Catabolism of intact type VI collagen microfibrils: susceptibility to degradation by serine proteinases,” Biochemical and Biophysical Research Communications, vol. 191, no. 3, pp. 1230–1236, 1993. View at Publisher · View at Google Scholar · View at Scopus
  110. D. Ribatti and G. Ranieri, “Tryptase, a novel angiogenic factor stored in mast cell granules,” Experimental Cell Research, 2014. View at Publisher · View at Google Scholar
  111. M. S. Stack and D. A. Johnson, “Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase),” The Journal of Biological Chemistry, vol. 269, no. 13, pp. 9416–9419, 1994. View at Google Scholar · View at Scopus
  112. L. B. Schwartz, T. R. Bradford, B. H. Littman, and B. U. Wintroub, “The fibrinogenolytic activity of purified tryptase from human lung mast cells,” Journal of Immunology, vol. 135, no. 4, pp. 2762–2767, 1985. View at Google Scholar · View at Scopus
  113. C. Huang, G. W. Wong, N. Ghildyal et al., “The tryptase, mouse mast cell protease 7, exhibits anticoagulant activity in vivo and in vitro due to its ability to degrade fibrinogen in the presence of the diverse array of protease inhibitors in plasma,” The Journal of Biological Chemistry, vol. 272, no. 50, pp. 31885–31893, 1997. View at Publisher · View at Google Scholar · View at Scopus
  114. B. L. Gruber, M. J. Marchese, K. Suzuki et al., “Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation,” The Journal of Clinical Investigation, vol. 84, no. 5, pp. 1657–1662, 1989. View at Publisher · View at Google Scholar · View at Scopus
  115. K. C. Fang, P. J. Wolters, M. Steinhoff, A. Bidgol, J. L. Blount, and G. H. Caughey, “Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta,” Journal of Immunology, vol. 162, no. 9, pp. 5528–5535, 1999. View at Google Scholar · View at Scopus
  116. T. Sendo, T. Sumimura, Y. Itoh et al., “Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells,” Cellular Signalling, vol. 15, no. 8, pp. 773–781, 2003. View at Publisher · View at Google Scholar · View at Scopus
  117. Y. Itoh, T. Sendo, T. Hirakawa et al., “Role of sensory nerve peptides rather than mast cell histamine in paclitaxel hypersensitivity,” The American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 1, pp. 113–119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  118. R. J. Blair, H. Meng, M. J. Marchese et al., “Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor,” The Journal of Clinical Investigation, vol. 99, no. 11, pp. 2691–2700, 1997. View at Publisher · View at Google Scholar · View at Scopus
  119. S. J. Compton, J. A. Cairns, S. T. Holgate, and A. F. Walls, “The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1β and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells,” The Journal of Immunology, vol. 161, no. 4, pp. 1939–1946, 1998. View at Google Scholar · View at Scopus
  120. L. M. Coussens, W. W. Raymond, G. Bergers et al., “Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis,” Genes and Development, vol. 13, no. 11, pp. 1382–1397, 1999. View at Publisher · View at Google Scholar · View at Scopus
  121. J. Lohi, I. Harvima, and J. Keski-Oja, “Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin,” Journal of Cellular Biochemistry, vol. 50, no. 4, pp. 337–349, 1992. View at Publisher · View at Google Scholar · View at Scopus
  122. R. Kaminska, P. Helisalmi, R. J. Harvima, A. Naukkarinen, M. Horsmanheimo, and I. T. Harvima, “Focal dermal-epidermal separation and fibronectin cleavage in basement membrane by human mast cell tryptase,” Journal of Investigative Dermatology, vol. 113, no. 4, pp. 567–573, 1999. View at Publisher · View at Google Scholar · View at Scopus
  123. M. Lees, D. J. Taylor, and D. E. Woolley, “Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B,” European Journal of Biochemistry, vol. 223, no. 1, pp. 171–177, 1994. View at Publisher · View at Google Scholar · View at Scopus
  124. W. Zhang, G. Stoica, S. I. Tasca, K. A. Kelly, and C. J. Meininger, “Modulation of tumor angiogenesis by stem cell factor,” Cancer Research, vol. 60, no. 23, pp. 6757–6762, 2000. View at Google Scholar · View at Scopus
  125. I. A. Akers, M. Parsons, M. R. Hill et al., “Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 278, no. 1, pp. L193–L201, 2000. View at Google Scholar · View at Scopus
  126. C. Lu, F. D. Zhao, X. B. Li, and L. H. Yin, “Up-regulation of interleukin-8 expressions induced by mast cell tryptase via protease activated receptor-2 in endothelial cell line,” Chinese Medical Journal (English Edition), vol. 118, no. 22, pp. 1900–1906, 2005. View at Google Scholar · View at Scopus
  127. X. Zhi, C. Xu, H. Zhang et al., “Tryptase promotes atherosclerotic plaque haemorrhage in ApoE-/- mice,” PLoS ONE, vol. 8, no. 4, Article ID e60960, 2013. View at Publisher · View at Google Scholar · View at Scopus
  128. T. A. McEachron, F. C. Church, and N. MacKman, “Regulation of thrombin-induced plasminogen activator inhibitor-1 in 4T1 murine breast cancer cells,” Blood Coagulation and Fibrinolysis, vol. 22, no. 7, pp. 576–582, 2011. View at Publisher · View at Google Scholar · View at Scopus
  129. T. A. McEachron, R. Pawlinski, K. L. Richards, F. C. Church, and N. Mackman, “Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis,” Blood, vol. 116, no. 23, pp. 5037–5044, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. A. F. Milia, M. B. Salis, T. Stacca et al., “Protease-activated receptor-2 stimulates angiogenesis and accelerates hemodynamic recovery in a mouse model of hindlimb ischemia,” Circulation Research, vol. 91, no. 4, pp. 346–352, 2002. View at Publisher · View at Google Scholar · View at Scopus
  131. M. Belting, M. I. Dorrell, S. Sandgren et al., “Regulation of angiogenesis by tissue factor cytoplasmic domain signaling,” Nature Medicine, vol. 10, no. 5, pp. 502–509, 2004. View at Publisher · View at Google Scholar · View at Scopus
  132. H. Mirza, V. Yatsula, and W. F. Bahou, “The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells: molecular characterization and evidence for functional coupling to the thrombin receptor,” Journal of Clinical Investigation, vol. 97, no. 7, pp. 1705–1714, 1996. View at Publisher · View at Google Scholar · View at Scopus
  133. C. Cicala, “Protease activated receptor 2 and the cardiovascular system,” British Journal of Pharmacology, vol. 135, no. 1, pp. 14–20, 2002. View at Publisher · View at Google Scholar · View at Scopus
  134. G. M. Hjortoe, L. C. Petersen, T. Albrektsen et al., “Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration,” Blood, vol. 103, no. 8, pp. 3029–3037, 2004. View at Publisher · View at Google Scholar · View at Scopus
  135. V. M. Shpacovitch, T. Brzoska, J. Buddenkotte et al., “Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells,” Journal of Investigative Dermatology, vol. 118, no. 2, pp. 380–385, 2002. View at Publisher · View at Google Scholar · View at Scopus
  136. N. Asokananthan, P. T. Graham, J. Fink et al., “Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells,” The Journal of Immunology, vol. 168, no. 7, pp. 3577–3585, 2002. View at Publisher · View at Google Scholar · View at Scopus
  137. Z. H. Wang, W. Zhu, J. P. Tao, Q. Y. Zhang, and M. Wei, “Stimulated mast cells promote maturation of myocardial microvascular endothelial cell neovessels by modulating the angiopoietin-Tie-2 signaling pathway,” Brazilian Journal of Medical and Biological Research, vol. 46, no. 11, pp. 920–928, 2013. View at Publisher · View at Google Scholar · View at Scopus
  138. H. Urata, A. Kinoshita, K. S. Misono, F. M. Bumpus, and A. Husain, “Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart,” The Journal of Biological Chemistry, vol. 265, no. 36, pp. 22348–22357, 1990. View at Google Scholar · View at Scopus
  139. Y. Kunori, M. Koizumi, T. Masegi et al., “Rodent α-chymases are elastase-like proteases,” European Journal of Biochemistry, vol. 269, no. 23, pp. 5921–5930, 2002. View at Publisher · View at Google Scholar · View at Scopus
  140. U. M. Chandrasekharan, S. Sanker, M. J. Glynias, S. S. Karnik, and A. Husain, “Angiotensin II-forming activity in a reconstructed ancestral chymase,” Science, vol. 271, no. 5248, pp. 502–505, 1996. View at Publisher · View at Google Scholar · View at Scopus
  141. G. H. Caughey, W. W. Raymond, and P. J. Wolters, “Angiotensin II generation by mast cell α- and β-chymases,” Biochimica et Biophysica Acta, vol. 1480, no. 1-2, pp. 245–257, 2000. View at Publisher · View at Google Scholar · View at Scopus
  142. S. Sanker, U. M. Chandrasekharan, D. Wilk, M. J. Glynias, S. S. Karnik, and A. Husain, “Distinct multisite synergistic interactions determine substrate specificities of human chymase and rat chymase-1 for angiotensin II formation and degradation,” The Journal of Biological Chemistry, vol. 272, no. 5, pp. 2963–2968, 1997. View at Publisher · View at Google Scholar · View at Scopus
  143. M. W. Kofford, L. B. Schwartz, N. M. Schechter, D. R. Yager, R. F. Diegelmann, and M. F. Graham, “Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide,” The Journal of Biological Chemistry, vol. 272, no. 11, pp. 7127–7131, 1997. View at Publisher · View at Google Scholar · View at Scopus
  144. K. C. Fang, W. W. Raymond, S. C. Lazarus, and G. H. Caughey, “Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase,” The Journal of Clinical Investigation, vol. 97, no. 7, pp. 1589–1596, 1996. View at Publisher · View at Google Scholar · View at Scopus
  145. E. Tchougounova, A. Lundequist, I. Fajardo, J.-O. Winberg, M. Åbrink, and G. Pejler, “A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2,” The Journal of Biological Chemistry, vol. 280, no. 10, pp. 9291–9296, 2005. View at Publisher · View at Google Scholar · View at Scopus
  146. B. T. Frank, J. C. Rossall, G. H. Caughey, and K. C. Fang, “Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase,” Journal of Immunology, vol. 166, no. 4, pp. 2783–2792, 2001. View at Publisher · View at Google Scholar · View at Scopus
  147. A. Nakano, F. Kishi, K. Minami, H. Wakabayashi, Y. Nakaya, and H. Kido, “Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells,” Journal of Immunology, vol. 159, no. 4, pp. 1987–1992, 1997. View at Google Scholar · View at Scopus
  148. S. Takai, N. Shiota, D. Jin, and M. Miyazaki, “Chymase processes big-endothelin-2 to endothelin-2-(1–31) that induces contractile responses in the isolated monkey trachea,” European Journal of Pharmacology, vol. 358, no. 3, pp. 229–233, 1998. View at Publisher · View at Google Scholar · View at Scopus
  149. J. Taipale, J. Lohi, J. Saarinen, P. T. Kovanen, and J. Keski-Oja, “Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells,” The Journal of Biological Chemistry, vol. 270, no. 9, pp. 4689–4696, 1995. View at Publisher · View at Google Scholar · View at Scopus
  150. G. Pejler and A. Karlstrom, “Thrombin is inactivated by mast cell secretory granule chymase,” The Journal of Biological Chemistry, vol. 268, no. 16, pp. 11817–11822, 1993. View at Google Scholar · View at Scopus
  151. G. H. Caughey, “New developments in the genetics and activation of mast cell proteases,” Molecular Immunology, vol. 38, no. 16–18, pp. 1353–1357, 2002. View at Publisher · View at Google Scholar · View at Scopus
  152. L. Lindstedt, M. Lee, and P. T. Kovanen, “Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid,” Atherosclerosis, vol. 155, no. 1, pp. 87–97, 2001. View at Publisher · View at Google Scholar · View at Scopus
  153. H. Urata, S. Hoffmann, and D. Ganten, “Tissue angiotensin II system in the human heart,” European Heart Journal, vol. 15, pp. 68–78, 1994. View at Google Scholar · View at Scopus
  154. T. Terada and Y. Matsunaga, “Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma,” Journal of Hepatology, vol. 33, no. 6, pp. 961–966, 2000. View at Publisher · View at Google Scholar · View at Scopus
  155. S.-Y. Tan, Y. Fan, H.-S. Luo, Z.-X. Shen, Y. Guo, and L.-J. Zhao, “Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer,” World Journal of Gastroenterology, vol. 11, no. 8, pp. 1210–1214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  156. A. Cabanillas-Saez, J. A. Schalper, S. M. Nicovani, and M. I. Rudolph, “Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix,” International Journal of Gynecological Cancer, vol. 12, no. 1, pp. 92–98, 2002. View at Publisher · View at Google Scholar · View at Scopus
  157. M. Muramatsu, J. Katada, I. Hayashi, and M. Majima, “Involvement of chymase in angiogenesis in hamster sponge granulomas,” Nihon Yakurigaku Zasshi, vol. 114, supplement 1, pp. 48P–54P, 1999. View at Google Scholar
  158. M. Muramatsu, M. Yamada, S. Takai, and M. Miyazaki, “Suppression of basic fibroblast growth factor-induced angiogenesis by a specific chymase inhibitor, BCEAB, through the chymase-angiotensin-dependent pathway in hamster sponge granulomas,” British Journal of Pharmacology, vol. 137, no. 4, pp. 554–560, 2002. View at Publisher · View at Google Scholar · View at Scopus
  159. J. Katada, M. Muramatsu, I. Hayashi, M. Tsutsumi, Y. Konishi, and M. Majima, “Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas,” The Journal of Pharmacology and Experimental Therapeutics, vol. 302, no. 3, pp. 949–956, 2002. View at Publisher · View at Google Scholar · View at Scopus
  160. J. M. Arbeit, K. Münger, P. M. Howley, and D. Hanahan, “Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice,” Journal of Virology, vol. 68, no. 7, pp. 4358–4368, 1994. View at Google Scholar · View at Scopus
  161. L. M. Coussens and Z. Werb, “Matrix metalloproteinases and the development of cancer,” Chemistry and Biology, vol. 3, no. 11, pp. 895–904, 1996. View at Publisher · View at Google Scholar · View at Scopus
  162. E. I. Deryugina and J. P. Quigley, “Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions,” Biochimica et Biophysica Acta, vol. 1803, no. 1, pp. 103–120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  163. A. Russo, G. Russo, M. Peticca, C. Pietropaolo, M. Di Rosa, and T. Iuvone, “Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: role of mast cell protease-5,” British Journal of Pharmacology, vol. 145, no. 1, pp. 24–33, 2005. View at Publisher · View at Google Scholar
  164. I. G. Rojas, M. L. Spencer, A. Martínez, M. A. Maurelia, and M. I. Rudolph, “Characterization of mast cell subpopulations in lip cancer,” Journal of Oral Pathology and Medicine, vol. 34, no. 5, pp. 268–273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  165. M. Białas, G. Dyduch, J. Szpor, S. Demczuk, and K. Okoń, “Microvascular density and mast cells in benign and malignant pheochromocytomas,” Polish Journal of Pathology, vol. 63, no. 4, pp. 235–242, 2012. View at Publisher · View at Google Scholar · View at Scopus
  166. T. Globa, L. Şaptefrţi, R. A. Ceauşu, P. Gaje, A. M. Cimpean, and M. Raica, “Mast cell phenotype in benign and malignant tumors of the prostate,” Polish Journal of Pathology, vol. 2, pp. 147–153, 2014. View at Publisher · View at Google Scholar
  167. M. Wilk, Ł. Liszka, P. Paleń, A. Gabriel, and P. Laudański, “Intensity of angiogenesis and mast cell infiltration in cervical intraepithelial and invasive lesions—are they correlated?” Pathology Research and Practice, vol. 206, no. 4, pp. 217–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  168. M. Nagata, N. Shijubo, A. F. Walls, S. Ichimiya, S. Abe, and N. Sato, “Chymase-positive mast cells in small sized adenocarcinoma of the lung,” Virchows Archiv, vol. 443, no. 4, pp. 565–573, 2003. View at Publisher · View at Google Scholar · View at Scopus
  169. S. T. Tan, R. A. Wallis, Y. He, and P. F. Davis, “Mast cells and hemangioma,” Plastic and Reconstructive Surgery, vol. 113, no. 3, pp. 999–1011, 2004. View at Publisher · View at Google Scholar · View at Scopus